Nephrology and Fluid/Electrolyte Physiology: Neonatology Questions
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Review Article NATRIURETIC PEPTIDES in CARDIOVASCULAR
CELLULAR & MOLECULAR BIOLOGY LETTERS http://www.cmbl.org.pl Received: 18 January 2007 Volume 13 (2008) pp 155-181 Revised form accepted: 08 May 2007 DOI: 10.2478/s11658-007-0046-6 Published online: 29 October 2007 © 2007 by the University of Wrocław, Poland Review article NATRIURETIC PEPTIDES IN CARDIOVASCULAR DISEASES MARIUSZ PIECHOTA1, MACIEJ BANACH2*, ANNA JACOŃ3 and JACEK RYSZ4 1Department of Anaesthesiology and Intensive Care Unit, Boleslaw Szarecki University Hospital No. 5 in Łódź, Medical University in Łódź, Poland, 2Department Cardiology, 1st Chair of Cardiology and Cardiac Surgery, University Hospital No. 3 in Łódź, Medical University in Łódź, Poland, 3Department of Health Protection Policy, Medical University of Łódź, Poland 42nd Department of Family Medicine, University Hospital No. 2 in Łódź, Medical University in Łódź, Poland Abstract: The natriuretic peptide family comprises atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), C-type natriuretic peptide (CNP), dendroaspis natriuretic peptide (DNP), and urodilatin. The activities of natriuretic peptides and endothelins are strictly associated with each other. ANP and BNP inhibit endothelin-1 (ET-1) production. ET-1 stimulates natriuretic peptide synthesis. All natriuretic peptides are synthesized from polypeptide precursors. Changes in natriuretic peptides and endothelin release were observed in many cardiovascular diseases: e.g. chronic heart failure, left ventricular dysfunction and coronary artery disease. Key words: Atrial natriuretic peptide, Brain natriuretic -
Appendix A—Digest of Other White House Announcements
Appendix A—Digest of Other White House Announcements The following list includes the President’s public January 7 schedule and other items of general interest an- In the morning, the President had an intel- nounced by the Office of the Press Secretary ligence briefing. Later, he traveled to Chicago, and not included elsewhere in this book. IL. In the afternoon, he returned to Wash- ington, DC. January 1 The President announced his intention to ap- In the morning, at the Bush Ranch in point Steven I. Cooper as Chief Information Crawford, TX, the President had an intelligence Officer at the Department of Homeland Secu- briefing. rity. January 2 January 8 In the morning, the President had a CIA In the morning, the President had intelligence briefing and a teleconference meeting with Vice and FBI briefings and met with the National President Dick Cheney. Security Council. January 3 In the afternoon, in the Roosevelt Room, the In the morning, the President had an intel- President met with members of the Commission ligence briefing. Later, he and Mrs. Bush trav- on Excellence in Special Education. eled to Fort Hood in Killeen, TX. The White House announced that the Presi- In the afternoon, the President and Mrs. Bush dent will host President Aleksander Kwasniewski had lunch with troops in Theodore Roosevelt of Poland for lunch on January 14 to discuss Hall. Later, they returned to the Bush Ranch key bilateral issues including the situation in in Crawford, TX. Iraq and cooperation against terrorism. The President announced his intention to The President declared a major disaster in nominate Ross Owen Swimmer to be Special South Carolina and ordered Federal aid to sup- Trustee for American Indians at the Department plement State and local recovery efforts in the of the Interior. -
2009-2010 Catalogue Peptide
20092010 Peptide Catalogue Generic Peptides Cosmetic Peptides Catalogue Peptides Designer BioScience Ltd Designer BioScience Table of Contents Ordering Information........................................................................................................................................2 Terms and Conditions.......................................................................................................................................3 Generic Peptides...............................................................................................................................................5 Cosmetic peptides...........................................................................................................................................10 Catalogue Peptides..........................................................................................................................................11 Custom Peptide Synthesis.............................................................................................................................292 Alphabetical Index........................................................................................................................................294 Catalogue Number Index..............................................................................................................................319 Designer BioScience Ltd, St John's Innovation Centre, Cambridge, CB4 0WS, United Kingdom Tel.: +44 (0) 1223 322931 Fax: +44 (0) 808 2801 506 [email protected] -
The Expression of Bradykinin and Its Receptors in Spinal Cord Ischemia
Life Sciences 218 (2019) 340–345 Contents lists available at ScienceDirect Life Sciences journal homepage: www.elsevier.com/locate/lifescie The expression of bradykinin and its receptors in spinal cord ischemia- T reperfusion injury rat model ⁎ Zheng Ma, Quan Dong, Boqiang Lyu, Jubo Wang, Yu Quan, Shouping Gong Department of Neurosurgery, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi Province 710014, PRChina ARTICLE INFO ABSTRACT Keywords: Objective: To investigate the expression and time-dependent manner of bradykinin (BK) as well as its receptors Spinal cord ischemia-reperfusion injury (Bradykinin receptors 1 and 2, B1R and B2R) in spinal cord ischemia-reperfusion injury (SCII) in rat model. Bradykinin Methods: Sprague-Dawley (SD) rats were subjected to 1 h of infra-renal abdominal aorta occlusion and re- Bradykinin receptors perfused for 3 h to 5 d to induce SCII. The concentration of BK in serum was detected by enzyme linked im- Kallikrein–kinin system munosorbent assay (ELISA). In situ expression of BK receptors was evaluated by immunochemistry and their mRNA level was evaluated by Real time quantitative-PCR (RTq-PCR). Results: The concentration of BK in serum was increased right after following SCII. Both of the BK receptors were detected and up-regulated in 24 h and 48 h after injury. The levels of B1R and B2R mRNA were up-regulated after SCII, and the B1R mRNA dropped to basal level after 6 h, but B2R mRNA dropped to lower level right after injury, peaked at 3 h, then remained a lower level from 6 h till 5 day. -
Beeper PAID Permit No
S1 9ROXPH;1R;Volume 21 • No. 8 Wednesday, Wednesday, MonthApril 20, X, 2011 2011 Sullivan to speak at GHSU graduation By Jennifer Hilliard Scott of Harvard Medical School, Boston City Hospital. Eight-hundred-and-two future Sullivan became the founding health care professionals will be Dean and Director of the Medical recognized as the newest graduates Education Program at Morehouse of Georgia Health Sciences Univer- College in 1975, which became the sity at 2 p.m. Thursday, May 5, at School of Medicine at Morehouse Augusta’s James Brown Arena. College in 1978, admitting its first Dr. Louis Wade Sullivan, former 24 students into a two-year program U.S. Department Health and Human in the basic medical sciences. He Services Secretary and a founder of was named President in 1981, when the Morehouse School of Medicine, the school received provisional ac- will be the guest speaker for this creditation. year’s commencement. Sullivan left Morehouse in 1989 Born in Atlanta, Sullivan at- to accept an appointment by Presi- Dr. Steven Greer (left) and Dr. Monte Hunter will lead a team tended Morehouse College, where dent George H.W. Bush to serve of nationally certified athletic trainers in providing care for the he graduated magna cum laude in as Secretary of the Department of Augusta GreenJackets. 1954. He graduated from Boston Health and Human Services. His University Medical School and accomplishments included introduc- completed an internal medicine ing a new and improved FDA food Ripken Baseball partners residency at the Weill Medical Col- label; preventing the introduction of lege of Cornell University; a clinical “Uptown,” a non-filtered, mentho- Former Health and Human lated cigarette; and inaugurating a fellowship in pathology at Massa- Services Secretary Dr. -
Wo 2009/034134 A2
(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date PCT (10) International Publication Number 19 March 2009 (19.03.2009) WO 2009/034134 A2 (51) International Patent Classification: (74) Agents: MEYERS, Hans-Wilhelm et al; Patent Attor A61K 38/17 (2006.01) C07K 14147 (2006.01) neys von KreislerSelting Werner, P.O. Box 10 22 41, 50462 A61F 13/00 (2006.01) Cologne (DE). (81) Designated States (unless otherwise indicated, for every (21) International Application Number: kind of national protection available): AE, AG, AL, AM, PCT/EP2008/062067 AO, AT,AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, (22) International Filing Date: EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, 11 September 2008 (11.09.2008) IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, (25) Filing Language: English MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY,TJ, (26) Publication Language: English TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW (30) Priority Data: (84) Designated States (unless otherwise indicated, for every 071 16164.0 11 September 2007 (11.09.2007) EP kind of regional protection available): ARIPO (BW, GH, 08100213.1 8 January 2008 (08.01.2008) EP GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM), (71) Applicant (for all designated States except US): PHARIS European (AT,BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, BIOTEC GMBH [DE/DE]; Feodor-Lynen-Strasse 31, FR, GB, GR, HR, HU, IE, IS, IT, LT,LU, LV,MC, MT, NL, 30625 Hannover (DE). -
Urodilatin-Renal Natriuretic Peptide?
Urodilatin-Renal stimulates particulate guanylate cyclase in these cells, also with equal potency to ANP (12). Because Natriuretic Peptide? this new peptide possesses vasorelaxant properties when tested in an in vitro bioassay system ( 1 1 ), these authors termed it urodilatin, in parallel with the term In 1 98 1 , the report by DeBold et a!. (1) of potent cardiodilatin that they had earlier suggested for the natriuretic activity in extracts of cardiac atria ush- name of the precursor peptide (13). ered In the era of atrial natriuretic peptide (ANP). In Little is known at this juncture of the site of syn- just a few short years, the amino acid sequences of thesis and secretion and the mechanism of action of ANP and its prohormone were determined and its this newest member of the natriuretic peptide family. gene structure was elucidated, and the tissues in The absence of detectable urodilatin in the circula- which it was synthesized were Identified (for review. tion (1 4) argues for a kidney-specific site of synthesis. see references 2 and 3). At the same time, the biolog- Immunohlstochemical studies and radioimmuno- ical actions of ANP were being recognized as poten- assay of renal extracts demonstrate a-ANP immu- tially key to the integration of cardiovascular and noreactivity in renal tissue, interpreted to show renal function and the control of body fluid volumes; either de novo synthesis of the peptide or internali- receptors were identified and characterized in target zation of circulating a-ANP by the kidneys (15,16). tissues, and the cellular actions of the peptide were Because the addition of four amino acids to the 28- related to activation of a membrane-bound guanylate amino-acid a-ANP taken up by renal cells from the cyclase with production of cGMP (2,3). -
2021 That Perform Diagnostics DRG Diagnostics
2021 Diagnostics that perform DRG Diagnostics DRG Instruments GmbH, founded in 1973 as a subsidiary DRG Instruments GmbH, mit Sitz in Marburg, wurde im Jahre of DRG Intl. Inc., USA, is a diagnostics manufacturer and 1973 als Niederlassung von DRG International, Inc. USA distributor with successful operations in over 110 countries. gegründet. Heute widmet sich die Firma hauptsächlich der The DRG Group focuses on high technology medical Entwicklung, Produktion und dem weltweiten Vertrieb von diagnostic areas such as Diabetes Diagnosis, Gynecology, neuen und innovativen ELISA Testsystemen. Oncology, Immunology, Infectious Diseases and Toxicology. The highly skilled DRG staff of medical, clinical, marketing and Technologie service specialists is experts at taking innovative technology to DRG arbeitet ständig daran die neuesten wissenschaftlichen market through local territory knowledge and contacts, end- und klinischen Erkenntnisse in Bereichen wie Diabetes, user training, education and cost effective financial and logistical Gynäkologie, Onkologie und Virologie und ihrer Diagnostik support. The DRG-Development and Immunoassay production in die Neu- und Weiterentwicklung von Immunoassays mit facilities are located in Marburg, Germany, in addition to OEM einzubeziehen. manufacturing in the USA. Die enge Kooperation mit unseren Kunden hat es uns in der A wide range of new, occasionally unique, ELISA kits have been Vergangenheit immer ermöglicht auf die Anfrage und Wünsche developed. The DRG ELISA kits compete effectively in both des Diagnostika-Marktes schnell und effizient zu reagieren. price and performance in all major world diagnostics markets. Diese enge Form der Zusammenarbeit stellt einen zentralen Punkt unserer Entwicklungen dar, um die bekannt gute Qualität To complete the diagnostic reagent line, DRG supplies the unserer Produkte und unseres Kundenservices weiter zu clinical laboratory with all necessary equipment, including a verbessern. -
Increased Atrial Natriuretic Peptide Mrna Expression in the Kidney of Diabetic Rats
View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Kidney International, Vol. 51(1997), pp. 1100—1105 Increased atrial natriuretic peptide mRNA expression in the kidney of diabetic rats SHYI-JANG SHIN, YAU-JIUNN LEE, MIAN-SHIN TAN, TusTY-JIuAN HSJEH, and JuEI-HsIuNG TSAI Division of Endocrinology and Metabolism, Graduate Institute of Medicine, Kaohsiung Medical College, Kaohsiung, Taiwan Increased atrial natriuretic peptide mRNA expression in the kidney of transcription-polymerase chain reaction (RT-PCR) followed by diabetic rats. To investigate whether renal synthesis of atrial natriuretiC Southern blot analysis, we recently demonstrated that renal ANP peptide (ANP) is influenced in diabetes, we measured renal ANP mRNA levels, urine volume, urinary ANP and sodium excretion rates in strepto- mRNA levels and urinary ANP excretion rates markedly in- zotocin (STZ)-induced diabetic rats. By using reverse transcription- creased in rats with deoxycorticosterone acetate-salt (DOCA-salt) polymerase chain reaction (RT-PCR) followed by Southern blot analysis, treatment [21]. The urinary ANP excretion rate was also found to we found that renal cortical and outer medullary ANP mRNA levels in be well correlated with urinary sodium excretion rate in DOCA- untreated diabetic rats were markedly increased as early as the second day salt rats. These observations suggest that renal-synthesized natri- after the onset of hyperglycemia and remained elevated for the entire 42-day study period. Plasma AMP concentrations in untreated diabetic uretic peptide, in addition to circulating ANP, may have a role in rats were increased on the 42nd day, whereas plasma renin activity were the renal regulation of sodium homeostasis. -
Pioneers in Diversity” Awards
The Office of Diversity and Inclusion invites nominations for the 2020 “Pioneers in Diversity” Awards Deadline for applications: Not currently accepting applications Each recipient will receive a $1,000 prize and a plaque in honor of their contributions to diversity. Nominations should include the following: • Nominee’s curriculum vitae highlighting his/her contributions • Nominee’s description of up to one page of how the nominee fulfills the selection criteria for this award Instructions on how to apply: • Documents should be emailed in PDF format with subject heading “Nominees for Pioneers in Diversity Award” to Elizabeth Omondi ([email protected]) • Please state each one of the four awards you are applying for in the subject heading of the PDF • Please provide the following items in the order listed as a single PDF file (single spaced, 12- point font, Arial with 1-inch margins) o Curriculum vitae (CV) /resume o Nomination (1 page document) • All PDF applications submitted should have the following document heading for the award you are applying for: “LastName.FirstInitial_PID_Award Name” o Examples: o Jones.F_PID_Ida Sophia Scudder.pdf o Jones.F_PID_Louis Wade Sullivan.pdf o Jones.F_PID_Bruce Laine Ballard.pdf o Jones.F_PID_Administrative Staff.pdf Self-nominations are welcome. Presentations of the award to recipients will be made at the 2019 Celebration of Diversity and Awards Ceremony during Diversity Week on April 27, 2020 Four “Pioneers in Diversity” Awards will be granted: • The Ida Sophia Scudder, M.D. Award for Excellence in Public Service awarded to a student. • The Bruce Laine Ballard, M.D. Award for Excellence in Mentorship awarded to a faculty member. -
The Legislative Recycling Bin: a Reevaluation of the Policy Process Angelina L
University of New Mexico UNM Digital Repository Political Science ETDs Electronic Theses and Dissertations Fall 11-7-2018 The Legislative Recycling Bin: A Reevaluation of the Policy Process Angelina L. González-Aller Follow this and additional works at: https://digitalrepository.unm.edu/pols_etds Part of the American Politics Commons Recommended Citation González-Aller, Angelina L.. "The Legislative Recycling Bin: A Reevaluation of the Policy Process." (2018). https://digitalrepository.unm.edu/pols_etds/81 This Dissertation is brought to you for free and open access by the Electronic Theses and Dissertations at UNM Digital Repository. It has been accepted for inclusion in Political Science ETDs by an authorized administrator of UNM Digital Repository. For more information, please contact [email protected]. i Angelina L. González-Aller Candidate Political Science Department This dissertation is approved, and it is acceptable in quality and form for publication: Approved by the Dissertation Committee: Michael S. Rocca, Chairperson Gabriel R. Sanchez Mala Htun Kate Cartwright ii THE LEGISLATIVE RECYCLING BIN: A REEVALUATION OF THE POLICY PROCESS by ANGELINA L. GONZÁLEZ-ALLER B.A. Political Science, University of New Mexico, 2008 M.A. Political Science, University of New Mexico, 2010 DISSERTATION Submitted in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy Political Science The University of New Mexico Albuquerque, New Mexico December 2018 iii DEDICATION Para mis hermanas. iv ACKNOWLEDGEMENTS I owe many people a great deal of thanks for helping me get here. I’d like to start with my committee, who continued to support me, even when the road was rocky and the years ticked by. -
Virginia Commonwealth University Commencement Program Virginia Commonwealth University
Virginia Commonwealth University VCU Scholars Compass VCU Commencement Programs VCU University Archives 1993 Virginia Commonwealth University Commencement Program Virginia Commonwealth University Follow this and additional works at: http://scholarscompass.vcu.edu/vcucommence © Virginia Commonwealth University Downloaded from http://scholarscompass.vcu.edu/vcucommence/28 This Program is brought to you for free and open access by the VCU University Archives at VCU Scholars Compass. It has been accepted for inclusion in VCU Commencement Programs by an authorized administrator of VCU Scholars Compass. For more information, please contact [email protected]. Vrrginia Commonwealth University Riclnnond,Vrrginia Commencement Program Twenty-Fifth Annual Commencement The Coliseum - May 22, 1993 Vrrginia Commonwealth University Riclunond,Vrrginia Commencement Program Tuenty-Fifth Annual Commencement The Coliseum May 22, 1993 The audience is respectfully asked not to enter onto the floor of the Coliseum until the ceremony has concluded and all graduates have left the Coliseum floor. BOARD OF VISITORS Virgini11 Commonwealth University Roger L. Gregory, Rector F. Dixon Whitworth, Jr., Vice Rector Rozanne G. Epps, Secretary Richard A. Arenstein Thomas J. Berenguer Constantine N. Dombalis Lawrence H. Frarnme, III Rohen D. Gilmer William E. Holland Harry I. Johnson, Jr. Richard L. Meador Clifton L. Peay Stuan C. Siegel Eva S. Teig Clarence L. Townes, Jr. Jay M. Weinberg PROGRAM Processional* Virginia Common wealth University Medley of works by Byrd, Symphonic Wind Ensemble Elgar, Washburn , Strauss. Terry L. Au stin, Conducting and Vaughan Williams Convocation* A. Patrick L. Prest, Jr. National Anthem VCU Symphonic Wind Ensemble Introduction of Guests Eugene P. Trani, President Commencement Address Louis W. Sullivan Conferring of Honorary Degrees Eugene P.